Global Biopharmaceutical Tubing Market - 2023-2030

Biopharmaceutical Tubing The Global Biopharmaceutical Tubing Market size reached USD 3,580.4 million in 2022 and is projected to witness lucrative growth by reaching up to USD 6,674.2 million by 2030. The biopharmaceutical tubing market is growing at a CAGR of 8.3% during the forecast period 2024–2031. The biopharmaceutical tubing market trend shows rising demand for these products owing to the rapid growth of single-use systems (SUS) in the biopharmaceutical industry, government and industry groups, which made a huge effort to develop uniform regularity for the integrity as well as purity of material required for tubing and other components.

The medical and biopharmaceutical sectors' crucial needs are specifically met by biopharmaceutical tubing. Extrusion is used to create biopharmaceutical tubing, which is widely utilized in peristaltic pumps, feeding tubes and drug administration systems.

Rising advantages of silicone tubing such as exceptional thermal, mechanical and chemical properties used in a wide range of applications, such as with anesthesiology and respiratory equipment, IVs and biopharmaceutical laboratory equipment will help in biopharmaceutical tubing market growth.

Market Dynamics

The Growing Application of Single-use Systems (SUS) Drives the Growth of the Market.

The global biopharmaceutical tubing value is expanding as a result of the growing application of single-use systems (SUS). Due to their established dependability, cost-effectiveness and general system resilience, single-use systems are being used for production in both upstream and downstream operations by biopharmaceutical companies. Single-use system components are incorporated utilizing flexible biopharmaceutical tubing comprising sterile connections to process transfer lines and other equipment.

Biopharmaceutical manufacturers worldwide count on biopharmaceutical tubing for reliable, single-use, sterile connectors, sterile disconnects and open-format products that improve yield, cut costs and reduce time to market. Single-use connectors integrate manufacturing assemblies into upstream and downstream processes in a wide range of applications, including scale-up, sampling, chromatography, filtration and final fill.

Rising Government Funding and Advantages Provided by this Tubing Create Lucrative Growth Opportunities for Manufacturers.

Government and industry organizations have expended a great deal of effort to develop universal standardization for material integrity and purity for tubing and other components due to the fast rise of single-use systems (SUS) in the biopharmaceutical industry.

The capacity of silicone tubing to endure sterilization procedures, the delivery of positive extractable substance test results and the lack of substances produced from animals. These industries have tubing requirements that are common to several applications in terms of performance, flexibility and cost.

A peristaltic pump or silicone tubing is frequently used in the manufacturing operations of pharmaceutical companies. The specifications for high purity, flexible, peristaltic pump tubing which may be welded and sealed, hence omitting several materials, are met by tubing materials like TPE. Certain TPEs, like silicone, can be molded into connections like Ys and Ts, which further reduces the requirement for fittings and the risk of leakage.

Cyclosiloxanes Contaminates in Biopharmaceutical Tubing May Hamper the Market Growth.

Drug producers are getting more and more concerned about the potential sources of contamination from processing machinery. The FDA claimed that contamination from processing equipment was the cause of 15% of medicine recalls in the past six months, which gives you an idea of the scope of the issue.

A primary area of concern is the direct contact of plastic processing materials that comprise single-use components with the drug product. It is well recognized that this may lead to the presence of substances that could impact the final drug's effectiveness, safety or quality. The effects on product development or brand integrity are substantial for manufacturers engaged in multi-million dollar pharmacological studies and treatments

Market Segment Analysis

The global biopharmaceutical tubing market is segmented based on type, application and region.

Owing to the Rising Demand, the Silicone Biopharmaceutical Tubing Segment will Hold 53.8% of the Biopharmaceutical Tubing Market Share.

Pt-catalyzed silicone tubing is beneficial due to its inherent purity, pliability, and ease of sterilization. Also, silicone materials are inert and biocompatible, with no side effects. Silicone tubing is a great option for processing in the pharmaceutical and biopharma industries because of its robustness, kink resistance, as well as pressure resistance.

A thermoset polymer called silicone can endure temperatures as low as -80 °C and as high as 215 °C. This silicone class passes the USP 88 Class VI tests and is not sensitizing, pyrogenic, cytotoxic, genotoxic or hemolytic.

For instance, W. L. Gore and Associates, Inc., GORE STA-PURE Pump Tubing, Series PCS, utilizes an exceptional, patented hybrid design that overpowers silicon tubing limitations. Even at pressures up to 100 PSIG, Series PCS tubing provides uniform flow rates. Series PCS offers high flex durability and high resilience standard sizes and is compatible with CIP/SIP and autoclave sterilization.

Likewise, the Masterflex peristaltic pump and platinum-cured silicone tubing provide excellent performance. It is not prone to tear or kinking. It is made to extremely tight tolerances, ensuring accurate, repeatable flow and a long tubing life. It has been factory tested and inspected visually.

Also, this platinum-cured silicone tubing is slightly clearer than peroxide-cured tubing. Actual performance varies depending on tubing formulation; silicone is only recommended for applications with a back pressure of 10 PSIG (0.7 bar) or less.

Market Geographical Share

North America Holds 40.5% of the Market Share Owing to the Strong Presence of Major Players and Increasing Healthcare Infrastructure Investment.

Due to the rising need for technological advancement in healthcare, North America, manufacturers have chances of enhancing their operations. There are many producers and suppliers in North America, and owing to the quick economic growth of the region, industrial production has been expanded, driving up the demand for biopharmaceutical tubing for processes in pharmaceutical companies.

Rising novel product launches to support biopharmaceutical tubing also drive market growth. For instance, in July 2022, DuPont, a technology-based solutions and materials provider company based in the U.S., announced that the newly constructed DuPont Liveo Healthcare production plant in Cooper River, South Carolina, would begin operations to serve clients throughout the world.

The Berkeley County facility will be run according to the same high standards as the company's venerable Hemlock, Michigan, biopharmaceutical manufacturing facility, the DuPont Healthcare Industries Materials Site.

In October 2021, to address customer demands and the healthcare sector's explosive growth, DuPont unveiled two new, significant product lines for its DuPont Liveo biopharmaceutical processing clients. TPE Tubing from Liveo Pharma - a variety of extruded thermoplastic elastomer (TPE) pharma tubing created using the same high-quality and high-purity standards as Liveo Silicone Pharma Tubing, specifically designed for fluid transfer and single-use bioprocessing applications.

Biopharmaceutical Tubing Companies

The major global players in the biopharmaceutical tubing market include W. L. Gore and Associates, Inc., Freudenberg Group (Freudenberg Medical), Rehu Group (RAUMEDIC AG), Genstar Capital (Tekni-Plex, Inc.), DuPont de Nemours, Inc., Holland Applied Technologies, Inc., Sartorius AG, Saint-Gobain, Ami Polymer and Nordson Corporation among others.

COVID-19 Impact on Market

Russia-Ukraine Conflict Analysis

Russia started its unlawful and unprovoked full-scale invasion of Ukraine, which resulted in sanctions against Russia from the US, the UN and other nations. In light of the current crisis, many businesses are starting to stop operating in Russia. These sanctions will surely have a significant effect on the worldwide market as businesses start to leave the Russian market. Due to worsening financial restrictions, the Russo-Ukrainian War will have a detrimental effect on the medical device industry in Russia.

Key Developments
• On August 9, 2022, DuPont declared that it would raise production capabilities for its Liveo Pharma Silicone Tubing by adding manufacturing capability in eastern China. Manufacturing expansion aims to meet the demand for high-performance, high-quality biopharmaceutical tubing in Greater China.
• On August 8, 2022, HelixTC over-molded sanitary ends in silicone have been introduced by Freudenberg Medical, a producer of medical or pharmaceutical devices, systems, elements, and tubing, for use in bioprocessing as well as single-use fluid transfer applications. The platinum-cured silicone tubing from Freudenberg's PharmaFocus Premium product line serves as the foundation for HelixTC, an alternative to conventional barbed TC connections.
• On October 12, 2021, DuPont launched new DuPont Liveo Pharma TPE tubing at upcoming trade shows. The addition of a line of extruded pharmaceutical tubing that utilizes thermoplastic elastomer (TPE) technology for fluid transportation and single-use bioprocessing applications marks an important turning point for the brand because it adheres to the same high-quality and high-performance standards as the Liveo Silicone Pharma Tubing range of products.

Why Purchase the Report?
• To visualize the global biopharmaceutical tubing- market segmentation based on type, application and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of biopharmaceutical tubing market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The Global Biopharmaceutical Tubing Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 Pages.

Target Audience 2024
• Manufacturers / Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies